July 9 (Reuters) - Medicines Co:
* Says got Paragraph IV certification from Hospira on ANDA to market a generic
version of Angiomax - SEC filing
* Says intends to vigorously defend its intellectual property rights
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Says got Paragraph IV certification from Hospira on ANDA to market a generic
version of Angiomax - SEC filing
* Says intends to vigorously defend its intellectual property rights
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.